Traci Green
Staff Affiliate - YNHHAbout
Research
Publications
2025
Characteristics and experiences of people who use drugs with involuntary civil commitment (Section 35) histories in Massachusetts: 2017 to 2022
Rapisarda S, Silcox J, Nace K, Shrestha S, Green T. Characteristics and experiences of people who use drugs with involuntary civil commitment (Section 35) histories in Massachusetts: 2017 to 2022. Journal Of Substance Use And Addiction Treatment 2025, 182: 209853. PMID: 41360292, DOI: 10.1016/j.josat.2025.209853.Peer-Reviewed Original ResearchInvoluntary civil commitmentCivil commitmentCo-use opioidsExperiences of PWUDMassachusetts lawSocial harmSubstance usePast-yearOverdose riskPWUDExperiences of peopleCommitmentIncarcerationLawMassachusettsHarmSurvey dataNaloxone administrationHealth outcomesBivariate statisticsFamily membersPeopleOverdose experiencesPreventive behaviorsOverdoseA descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states
Li Z, Chiddawar T, Shaw L, Dennis A, Lieberman A, Kingsepp A, Trinidad A, Tuazon E, Welch A, Chatterjee A, Schackman B, Enns E, Walley A, Green T, Wagner K, Winograd R, Behrends C, Crable E, Marshall B, Zang X. A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states. International Journal Of Drug Policy 2025, 147: 105100. PMID: 41351927, DOI: 10.1016/j.drugpo.2025.105100.Peer-Reviewed Original ResearchOverdose preventionDrug paraphernalia lawsNaloxone distribution ratesPrevention infrastructureOverdose epidemicOverdose prevention servicesHarm reduction servicesOverdose death ratesOverdose prevention effortsFunding per capitaLegal informationState lawsEnacting lawsParaphernalia lawsSettlement amountDrug overdose epidemicMortality trendsPreventive servicesRacial/ethnic disparitiesDrug overdose deathsLawSettlement fundsOverdose patternsReduction lawReduction servicesRepeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial
Coffin P, Santos G, McMahan V, Marti X, Matheson T, Brennan S, Arenander J, Robinson M, Farley J, Pope E, Rolles A, Kosakowski S, Green T, Walley A. Repeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial. Addiction 2025 PMID: 41261059, DOI: 10.1111/add.70252.Peer-Reviewed Original ResearchOpioid use disorderMotivational interviewing interventionPrimary outcomeUse disorderOpioid overdoseBehavioral interventionsMonths 0Non-prescribed opioid useInterviewing interventionPhase III randomized controlled trialsOccurrence of opioid overdoseOpioid use disorder treatmentOverdose eventsAttentional controlYears of agePost Hoc AnalysisTimeline FollowbackRandomized Controlled TrialsOpioid useOpioidSecondary outcomesStreet opioidsSingle-blindPersonalized prevention planFentanylFeasibility and Acceptability of Restroom Motion Sensors for Detecting Overdoses.
Park J, McKee H, Ramsey S, Rich J, Green T, Frank H, Chatterjee A, Rosen J. Feasibility and Acceptability of Restroom Motion Sensors for Detecting Overdoses. Substance Use & Addiction Journal 2025, 29767342251370822. PMID: 41006965, DOI: 10.1177/29767342251370822.Peer-Reviewed Original ResearchPerceived benefitsCommunity drop-in centerClient focus groupsDrop-in centersDrug use eventsPotential legal repercussionsCognitive burdenHarm reduction workersStigmatizing attitudesStaff fatigueCommunity settingsFocus groupsOverdose crisisEducational videosSensor implementationStaffImplementation effortsAnxietyFatal overdoseShelter staffVisual descriptionInterventionHousing programsData confidentialityParticipants“Now that I'm here, I actually have the stability and the time to really think about stuff like that”: Perspectives on medications for opioid use disorder in low-threshold harm reduction housing
Chatterjee A, Rapisarda S, Silcox J, Zaragoza S, Summers C, Rolles A, Kosakowski S, Green T. “Now that I'm here, I actually have the stability and the time to really think about stuff like that”: Perspectives on medications for opioid use disorder in low-threshold harm reduction housing. Journal Of Substance Use And Addiction Treatment 2025, 179: 209810. PMID: 41015388, PMCID: PMC12668795, DOI: 10.1016/j.josat.2025.209810.Peer-Reviewed Original ResearchConceptsPolicy approachesSubstance useThematic analysisSubstance use behaviorsCity of BostonU.S. citiesSemi-structured interviewsOff siteService accessDelivery of MOUDInterview dataMOUD accessOpioid use disorderHomelessnessGovernment entitiesPolicyHealth-related outcomesHRHEncampmentsUse behaviorsHRH interventionsHousingUse disorderQuality of lifeAccessibility issuesPoint‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances
Ujeneza M, Tardif J, Thompson E, Badea A, Morales A, Altomare‐Jarczyk C, Green T, Serafinski R, McKenzie M, Park J. Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances. Drug And Alcohol Review 2025, 44: 1866-1874. PMID: 40977066, DOI: 10.1111/dar.70037.Peer-Reviewed Original ResearchDrug categoriesLC-QTOF-MSPresence of cocaineDrug supplyLiquid chromatography-quadrupole time-of-flight mass spectrometryHarm reduction sitesHarm reduction educationCocaineTime-of-flight mass spectrometryFentanylOverdose riskReal-time FTIRFourier transform infrared (FTIR) spectroscopyDrug checking servicesService usersInfrared (FTIR) spectroscopyIllicit drug supplyReduction educationSemi-quantitative testDrugReduction siteXylazine Awareness and Suspected Presence in the Illicit Drug Supply Among People Who Used Stimulants in an Overdose Hotspot, 2023
Kelly P, Green T, Rich J, Vento S, Bailey A, Silva V, Noh M, Hughto J. Xylazine Awareness and Suspected Presence in the Illicit Drug Supply Among People Who Used Stimulants in an Overdose Hotspot, 2023. Substance Use & Misuse 2025, ahead-of-print: 1-10. PMID: 40888200, DOI: 10.1080/10826084.2025.2549501.Peer-Reviewed Original ResearchNon-HispanicPurposive sub-sampleBlack non-HispanicSubstance useNon-Hispanic participantsPercentage of participantsHigh school degreeIn-depth interviewsHarm-reduction messagesLiteracy-appropriateChi-square testLess educationTrusted messengersReduction messagesSurvey participantsSchool degreeCollege educationQualitative dataChi-squareIllicit drug supplyParticipantsOpioid useDrug supplyEffects of xylazineUse experienceKey-Informant Perspectives On Pharmacy-Based Methadone Treatment For Opioid Use Disorder In The US
Stewart M, Feltus S, Tschampl C, Bratberg J, Green T. Key-Informant Perspectives On Pharmacy-Based Methadone Treatment For Opioid Use Disorder In The US. Health Affairs 2025, 44: 1164-1172. PMID: 40893075, PMCID: PMC12519808, DOI: 10.1377/hlthaff.2025.00344.Peer-Reviewed Original ResearchCorrection: Developing a comprehensive inventory to define harm reduction housing
Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, Chatterjee A, Walley A, Komaromy M, Green T. Correction: Developing a comprehensive inventory to define harm reduction housing. Harm Reduction Journal 2025, 22: 142. PMID: 40826084, PMCID: PMC12363098, DOI: 10.1186/s12954-025-01290-0.Peer-Reviewed Original ResearchAmputation trends among people who use drugs in the context of Philadelphia’s increasingly xylazine adulterated drug supply
Laurano R, Pogorzelska-Maziarz M, Green T, Beachy S, Rising K, Hom J, Reed M. Amputation trends among people who use drugs in the context of Philadelphia’s increasingly xylazine adulterated drug supply. Drug And Alcohol Dependence 2025, 275: 112826. PMID: 40815910, DOI: 10.1016/j.drugalcdep.2025.112826.Peer-Reviewed Original ResearchInternational ClassificationFactors associated with amputationAssociated with amputationInternational Classification of DiseasesAcute care visitsIncidence of amputationClassification of diseasesDrug supplyTreatment completionMultivariate logistic regressionActive substance useCare visitsHealth providersRetrospective analysis of dataICD-10United StatesUnique patientsLogistic regressionAmputationDrug checkingOpioid related disordersOverdose deathsAnalysis of dataMedical examinationSubstance use